Uncategorized

Medicare NDC vs. FDA NDC

I was recently approached by one of our clinic customers which seeks Medicare or Medicaid reimbursement for pharmaceuticals dispensed to patients.  She asked me why the NDC (National Drug Code) for PCA labeled medications was only 10 digits while Medicaid was telling her that it requires an 11 digit NDC on its reimbursement application.  Many of our clinics stay out of the reimbursement game and only accept cash so this was the first time I had heard this question.  Looking into it, I discovered that the Deficit Reduction Act of 2005 requires states to collect rebates (from manufacturers) for physician administered medications.  This means they need to collect NDC information on products dispensed by physicians.

The NDC was created by the FDA and consists of 10 digits that identify the manufacturer, the product and the size of the product.  The first four or five digits identify the manufacturer, the second 3 or 4 digits identify the product and the last 1 or 2 digits identify the size.  For example, PCA Pharmaceuticals offers Lisinopril 5mg in 30 count bottles; the NDC for this product is 51655-232-24.  51655 indicates PCA, 232 indicates Lisinopril and 24 indicates a count of 30 tablets (that is FDA logic :).  The Medicare standard looks for 11 digits in an NDC so any NDC’s less than 11 need to be augmented with a 0.  The Medicare NDC requires a 5 digit-4 digit-2 digit format.  In the case of PCA’s Lisinopril product, this means that a 0 would be added before the second set of digits with the new NDC being 51655-0232-24.  Unfortunately for our clinic, the agency denied the claim but was not able to explain the logic to her.  The best explanation I’ve found is on the State of Massachusetts Health and Human Services website.

Medication dispensing with PCA focuses on cash pay customers but there are opportunities for clinics providing workers compensation services.  Clinics implementing our physician dispensing solution will be given any support needed to optimize this extra service relative to the focus of the practice.

Schedule a free claims analysis now.

Let’s Talk now

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading